MyLymphomaTeam

Yes, people with AITL have survived, and some have achieved remission. It's a tough diagnosis, but treatment can be effective for many people.

Chemotherapy has a strong response rate of 70–80%, which is encouraging. When combined with a stem cell transplant, the five-year progression-free survival rate rises to around 40% Show Full Answer

Yes, people with AITL have survived, and some have achieved remission. It's a tough diagnosis, but treatment can be effective for many people.

Chemotherapy has a strong response rate of 70–80%, which is encouraging. When combined with a stem cell transplant, the five-year progression-free survival rate rises to around 40%. Here are the main treatments that have shown results:

- CHOP or CHOEP chemotherapy — These are the most common first-line regimens combining several chemo drugs
- B-CHP — Adds a targeted drug (Adcetris/brentuximab vedotin) to chemotherapy, helping deliver treatment directly to cancer cells
- Stem cell transplant — Often used after high-dose chemo to reduce the chance of relapse
- Targeted therapies — For relapsed or treatment-resistant AITL, drugs like Istodax or Beleodaq may be used
- Clinical trials — An option worth exploring, especially for rare or hard-to-treat cases

Survival rates vary, and AITL is often diagnosed at an advanced stage, so outcomes differ from person to person. Talking with your oncologist about which combination is right for your specific situation is really important.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Angioimmunoblastic T-Cell Lymphoma — An Overview